Suchergebnisse - "RECOVERY Collaborative Group"

PubPharm (15)

1

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: The Lancet. Child & adolescent health | 2024

von RECOVERY Collaborative Group | Faust, S. | Haynes, R. | +98

2

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Nature communications | 2024

von RECOVERY Collaborative Group | Horby, P. | Peto, L. | +130

3

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: The lancet. Diabetes & endocrinology | 2023

von RECOVERY Collaborative Group | Abani, O. | Abbas, A. | +98

ErratumIn: Lancet Diabetes Endocrinol. 2024 Jan;12(1):e1. - PMID 38040017

4

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2023

von RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk | RECOVERY Collaborative Group | Abani, O. | +99

CommentIn: Lancet. 2023 May 6;401(10387):1474-1476. - PMID 37060914

5

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis

enthalten in: Lancet (London, England) | 2022

von RECOVERY Collaborative Group | Abani, O. | Abbas, A. | +98

CommentIn: Lancet. 2022 Jul 30;400(10349):338-339. - PMID 35908561

6

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2022

von RECOVERY Collaborative Group | Abani, O. | Abbas, A. | +98

CommentIn: Lancet. 2022 Feb 12;399(10325):609-610. - PMID 35151380

7

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2022

von RECOVERY Collaborative Group | Abani, O. | Abbas, A. | +98

CommentIn: Lancet. 2022 Jan 8;399(10320):118-119. - PMID 34800425

8

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: The Lancet. Respiratory medicine | 2021

von RECOVERY Collaborative Group

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1351-1353. - PMID 34688436

9

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2021

von RECOVERY Collaborative Group | Abani, O. | Abbas, A. | +98

CommentIn: Lancet. 2021 May 29;397(10289):2024-2025. - PMID 34000255

10

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: Lancet (London, England) | 2021

von RECOVERY Collaborative Group | Abani, O. | Abbas, A. | +98

CommentIn: Lancet. 2021 May 1;397(10285):1599-1601. - PMID 33933194